HER2 Support Group Forums - View Single Post - New data shows benefit of drug combination for metastatic castration resistant prosta

News · 09-19-2021, 02:12 PM

New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC).

More...

09-19-2021, 02:12 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,156	New data shows benefit of drug combination for metastatic castration resistant prosta New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC). More...